Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

BMS’ Opdivo/Yervoy combo cleared for kidney cancer

pharmatimesJuly 16, 2018

Tag: BMS , Kidney Cancer , BMS/ / / kidney cancer/ nivolumab/ sunitinib/ , BMS/ / / kidney cancer/ nivolumab/ sunitinib/

PharmaSources Customer Service